Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 14.61M | $ 1.85M | $ 1.11M | $ 1.24M | $ 2.23M |
Total Assets | $ 24.48M | $ 10.88M | $ 9.12M | $ 9.19M | $ 2.64M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 2.64M | $ 539.13K | $ 510.62K | $ 526.86K | $ 279.42K |
Stockholders Equity | $ 21.85M | $ 10.34M | $ 8.61M | $ 8.66M | $ 2.36M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |